chemistry of unusual synthetic promise.5 The nucleophilicity
at the nitrogen is a factor of essential mechanistic importance
in the use of these iminophosphoranes as aza-Wittig reagents.
Iminophosphoranes are important reagents in synthetic
organic chemistry, especially in the synthesis of naturally
occurring products, compounds with biological and phar-
macological activity.5 There are several reports for the use
of (N-isocyanimino)triphenylphosphorane 4 in the synthesis
of metal complexes. However, the organic chemistry of 4
remains almost unexplored. The (N-isocyanimino)triph-
enylphosphorane 4 is expected to have synthetic potential
because it provides a reaction system in which the imino-
phosphorane group can react with a reagent having a
carbonyl functionality (Scheme 1).6
analgesic, anticonvulsive, antiemetic, diuretic,11 tyrosinase
inhibitor,12 growth hormone secretagogues,13 benzodiazepine
receptor partial agonists,14 dopamine transporters,15 and 5-HT
agonists16 (Figure 1).
Figure 1. Examples of some biologically active 2,5-disubstituted
1,3,4-oxadiazole derivatives.
Several methods have been reported in the literature for
the synthesis of 1,3,4-oxadiazole heterocycles which are
multistep in nature. The most general method involves the
cyclization of diacylhydrazides with a variety of reagents,
such as thionyl chloride, phosphorus oxychloride, or sulfuric
acid, usually under harsh reaction conditions.17 Few reliable
and operationally simple examples have been reported for
the one-step synthesis of 1,3,4-oxadiazoles, especially from
readily available carboxylic acids and acid hydrazides.18
Therefore, development of a synthetic method that could be
used to prepare a variety of these templates remains an
important task.
Scheme 1
.
Synthesis of 2,5-Disubstituted 1,3,4-Oxadiazole
Derivatives 5a-o
As part of our ongoing program to develop efficient and
robust methods for the preparation of heterocyclic com-
pounds,19 herein we wish to report a fundamentally new
approach to the synthesis of 2,5-disubstituted 1,3,4-oxadia-
Oxadiazoles have often been described as bioisoesteres
for amides and esters. Due to the increased hydrolytic and
metabolic stability of the oxadiazole ring, improved phar-
macokinetic and in vivo performance is often observed,
which make this heterocycle an important structural motif
to the pharmaceutical industry.7 As a consequence of these
characteristics, 1,3,4-oxadiazoles have impacted numerous
drug discovery programs, including CNS stimulant, antiin-
flammatory, hypotensive,8 insecticidal,9 hypoglycemic,10
(11) Thomas, J. Ger. Pat. 2,403, 357/1974 [Chem. Abstr., 1974, 81,
136153g].
(12) Hassan Khan, M. T.; Choudhary, M. I.; Mohammed Khan, K.; Rani,
M.; Rahman, A. Bioorg. Med. Chem. 2005, 13, 3385.
(13) Ankersen, M.; Peschke, B.; Hansen, B. S.; Hansen, T. K. Bioorg.
Med. Chem. Lett. 1997, 7, 1293.
(14) Watjen, F.; Baker, R.; Engelstoff, M.; Herbert, R.; MacLeod, A.;
Knight, A.; Merchant, K.; Moseley, J.; Saunders, J.; Swain, C. J.; Wong,
E.; Springer, J. P. J. Med. Chem. 1989, 32, 2282.
(15) Carroll, F. I.; Gray, J. L.; Abrahm, P.; Kuzemko, M. A.; Lewin,
A. H.; Boja, J. W.; Kuhar, M. J. J. Med. Chem. 1993, 36, 2886.
(16) Chen, C.; Senanayake, C. H.; Bill, T. J.; Larsen, R. D.; Verhoeven,
T. R.; Reider, P. J. J. Org. Chem. 1994, 59, 3738.
(5) (a) Molina, P.; Vilaplana, M. J. Synthesis 1994, 1197. (b) Palacios,
F.; Aparicio, D.; Rubiales, G.; Alonso, C.; de los Santos, J. M. Curr. Org.
Chem. 2009, 13, 808. (c) Palacios, F.; Aparicio, D.; Rubiales, G.; Alonso,
C.; de los Santos, J. M. Curr. Org. Chem. 2006, 10, 2371. (d) Hajo´s, G.;
Nagy, I. Curr. Org. Chem. 2008, 12, 39. (e) Palacios, F.; Alonso, C.;
Aparicio, D.; Rubiales, G.; de los Santos, J. M. Tetrahedron 2007, 63, 523.
(f) Cossio, F. P.; Alonso, C.; Lecea, B.; Ayerbe, M.; Rubiales, G.; Palacios,
F. J. Org. Chem. 2006, 71, 2839. (g) Palacios, F.; Herra´n, E.; Alonso, C.;
Rubiales, G.; Lecea, B.; Ayerbe, M.; Coss´ıo, F. P. J. Org. Chem. 2006, 71,
6020.
(17) (a) Baxendale, I. R.; Ley, S. V.; Martinelli, M. Tetrahedron 2005,
61, 5323. (b) Liras, S.; Allen, M. P.; Segelstein, B. E. Synth. Commun.
2000, 30, 437. (c) Brain, C. T.; Brunton, S. A. Synlett 2001, 3, 382. (d)
Tandon, V. K.; Chhor, R. B. Synth. Commun. 2001, 31727. (e) Bentiss, F.;
Lagrenee, M.; Barbry, D. Synth. Commun. 2001, 31, 935. (f) Wang, Y.;
Sauer, D. R.; Djuric, S. W. Tetrahedron Lett. 2006, 47, 105.
(18) (a) Jedlovska, E.; Lesko, J. Synth. Commun. 1994, 24, 1879.
(19) (a) Ramazani, A.; Mahyari, T. M.; Rouhani, M.; Rezaei, A.
Tetrahedron Lett. 2009, 50, 5625. (b) Souldozi, A.; Ramazani, A.;
Bouslimani, N.; Welter, R. Tetrahedron Lett. 2007, 48, 2617. (c) Souldozi,
A.; Ramazani, A. Tetrahedron Lett. 2007, 48, 1549. (d) Ramazani, A.;
Souldozi, A. Phosphorus, Sulfur, Silicon Relat. Elem. 2004, 179, 529. (e)
Ramazani, A.; Bodaghi, A. Phosphorus, Sulfur, Silicon Relat. Elem. 2004,
179, 1615. (f) Ramazani, A.; Kazemizadeh, A. R.; Ahmadi, E. Phosphorus,
Sulfur, Silicon Relat. Elem. 2005, 180, 1781. (g) Ramazani, A.; Ahmadi,
E. Phosphorus, Sulfur, Silicon Relat. Elem. 2006, 181, 2725. (h) Heshmati-
Gonbari, M.; Ramazani, A.; Souldozi, A. Phosphorus, Sulfur, Silicon Relat.
Elem. 2009, 184, 309. (i) Yavari, I.; Ramazani, A.; Yahya-Zadeh, A. Synth.
Commun. 1996, 26, 4495. (j) Yavari, I.; Ramazani, A. Synth. Commun.
1996, 26, 4495. (k) Adib, M.; Kesheh, R. M.; Ansari, S.; Bijanzadeh, R. H.
Syn. Lett. 2009, 10, 1575. (l) Adib, M.; Ansari, S.; Bijanzadeh, R. H. Syn.
Lett. 2010, 6, 0921. (m) Adib, M.; Ansari, S.; Fatemi, S.; Bijanzadeh, H. R.;
Zhu, L.-G. Tetrahedron 2010, 66, 2723.
(6) (a) Stolzenberg, H.; Weinberger, B.; Fehlhammer, W. P.; Pu¨hlhofer,
F. G.; Weiss, R. Eur. J. Inorg. Chem. 2005, 21, 4263. (b) Chiu, T. W.; Liu,
Y. H.; Chi, K. M.; Wen, Y. S.; Lu, K. L. Inorg. Chem. 2005, 44, 6425.
(7) (a) Borg, S.; Estenne-Bouhtou, G.; Luthman, K.; Csoregh, I;
Hesselink, W.; Hacksell, U. J. Org. Chem. 1995, 60, 3112. (b) Clapp, L. B.
AdV. Heterocycl. Chem. 1976, 65.
(8) Deshmukh, A. A.; Sattur, P. B.; Sheth, U. K. Indian J. Exp. Biol.
1976, 4, 166.
(9) Sen Gupta, A. K.; Garg, M.; Chandra, U. J. Indian Chem. Soc. 1979,
56, 1230.
´
(10) (a) O Neal, J. B.; Rosen, H.; Russel, P. B.; Adams, A. C.;
Blumenthal, A. J. Med. Pharm. Chem. 1962, 5, 617. (b) Kurzer, F. Org.
Compd. Sulphur, Selenium, Tellurium 1974, 4, 417.
Org. Lett., Vol. 12, No. 12, 2010
2853